Related Experiment Video
Updated: Apr 20, 2026
08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
54.2K
Perspectives of CD44 targeting therapies
1Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, Postfach 3640, 76021, Karlsruhe, Germany, veronique.orian-rousseau@kit.edu.
Archives of Toxicology
|December 5, 2014
Summary
Targeting CD44, a transmembrane glycoprotein involved in cancer stem cells, offers promising therapeutic strategies. Understanding specific CD44 isoforms is key to successful cancer treatment approaches.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- CD44 is a transmembrane glycoprotein family with diverse isoforms.
- CD44 plays roles in physiological processes and cancer, including cancer stem cell identification.
- CD44 functions as a receptor for hyaluronan and a co-receptor for signaling pathways.
Purpose of the Study:
- To review therapeutic strategies targeting CD44 in cancer.
- To highlight the role of CD44 isoforms in cancer stem cells.
- To emphasize the need for deeper understanding of CD44 functions.
Main Methods:
- Review of literature on CD44 biology and cancer therapy.
- Analysis of CD44's role in cancer stem cell populations.
- Discussion of various targeting approaches for CD44.
Main Results:
- CD44 isoforms are implicated in cancer stem cell populations.
- Multiple strategies exist for targeting CD44, including antibodies, peptides, and expression inhibition.
- CD44's hyaluronan receptor function can be therapeutically exploited.
Conclusions:
- Targeting CD44 presents a viable strategy for cancer therapy.
- Further research into specific CD44 isoform functions, particularly in cancer stem cells, is crucial for therapeutic success.
Related Concept Videos
02:57Targeted Cancer Therapies
9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.2K
02:57Targeted Cancer Therapies
1.8K
1.8K
01:27Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
02:50Combination Therapies and Personalized Medicine
6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
01:24Modified-Release Drug Delivery Systems: Site-Targeted
144
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
144
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
74
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
74